期刊文献+

端粒酶催化亚基反义寡核苷酸对食管癌细胞的抑制作用 被引量:2

Inhibition of antisense oligodeoxynucleotides of human telomerase reverse transcription on esophageal carcinoma
下载PDF
导出
摘要 目的:探讨人端粒酶催化亚基(human telomerase reserse transcription,hTERT)反义寡核苷酸(antisense oligodeoxynucleotide,ASODN)对食管癌细胞株Eca-109端粒醇活性的影响,及其对癌细胞的生长抑制作用。方法:MTT比色法测定ASODN对Eca-109细胞的生长抑制率;倒置显微镜观察5μmol/L的ASODN作用于Eca-109癌细胞10d后的细胞形态学改变;端粒酶活性检测采用半定量TRAP-银染法。结果:ASODN对Eca-109细胞的生长抑制作用具有剂量及时间依赖性和序列特异性。ASDON作用后,Eca-109细胞的生长速度缓慢,细胞间连接疏松。细胞变圆漂起,细胞体积缩小。随作用时间延长,ASODN对Eca-109细胞端粒酶活性的抑制作用逐渐增强,1~15d,相对端粒酶活性95~22。呈时间-依赖性;随药物浓度增加,ASODN对Eca-109细胞端粒醇活性的抑制作用逐渐增强,1~5μmol/L相对端粒酶活性86~14。呈浓度-依赖性。结论:端粒酶催化亚基反义寡核苷酸对食管癌具有重要治疗价值,有望成为食管癌治疗的潜在途径。 OBJECTIVE: To evaluate the effect of human telomerase reverse transcriptase (hTERT) gene antisense oligodeoxynucleotide (ASODN) on telomerase activity of human esophagus cancer cell line Eca-109. METHODS: MTT clorimetry was used to determine the cell growth inhibitory rate. Microscope was adopted to examine the morphologic changes of cells after Eca-109 was given 5μmol/L PS-ASODN for 10 d. Telomerase activity was detected by silver staining semi-quantitative TRAP assay. RESULTS: ASODN could, inhibit telomerase activity and proliferation of Eca-109 cell line in a dose and period dependent manner retative telamerase activity: 1 -15 d, 95 - 22; 1 - 5 μmol/L 86- 14. The growth rate of cells was reduced by ASDON. Cells became round, suspended and small. CONCLUSION: ASODN of human telomerase reserse transcription can inhibit telomerase activity and cell proliferation of Eca-109 cell line, suggesting that ASODN implied an important value for treatment of esophagus cancer.
出处 《中华肿瘤防治杂志》 CAS 2006年第23期1773-1776,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 食管肿瘤 端粒 末端转移酶 寡核苷酸类 反义 esophageal neoplasms telomerase oligonucleotides, antisensc
  • 相关文献

参考文献10

  • 1De Lange T.Activation of telomerase in a human tumor[J].Proe Natl Acad Sci U S A,1994,91(18):2882-2885.
  • 2Zakian V A.Telomeres:beginning to understand the end.Science[J].1995,270(5244):1601-1607.
  • 3Wright W E,Piatyszek M A,Shay J W,et al.Experimental elongation of telomeres in immortal human cells extends the lifespan of immortal/normal cell hybrids[J].EMBOJ,1996,15 (1):1734-1741.
  • 4Dahse R,Fiedler W,Ernst G.Telomere and telomerase:biological and clinical importance[J].Clin Chem,1997,43 (16):708-714.
  • 5Feng J,Funk W O,Wang S S,et al.The RNA component of human telomerase[J].Science,1995,269(5228):1236-1241.
  • 6王涛,张伟,金顺钱,张德超,刘毅,林培中.食管癌组织中端粒酶活性的研究[J].中华医学杂志,1998,78(10):785-786. 被引量:14
  • 7Kim N W,Piatyszek M A,Prowse K R,et al.Specific association of humon telomerase activity with immotal cells and cancers[J].Science,1994,266(5193):2011-2015.
  • 8Ito H,Kyo S,Kanaya T,et al.Expression of human telomerase submits and correlation with telomerase activity in urothelial cancer[J].Clin Cancer Res,1999,4(7):1603-1608.
  • 9Kushner D M,Paranjape J M,Bandyopadhyay B,et al.2-5A antisense directed against telomerase RNA Produces apoptosis in ovarian cancer cells[J].Gynecol Oncol,2000,76 (2):183-192.
  • 10Kondo Y,Koga S,Komata T,et al.Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component[J].Oncogene,2000,19 (18):2205-2211.

二级参考文献1

  • 1Mao L,Cancer Res,1996年,56卷,5600页

共引文献13

同被引文献11

  • 1王立东.食管和贲门癌癌变多阶段演进机制[J].中华肿瘤防治杂志,2006,13(5):321-324. 被引量:33
  • 2邹小农.食管癌流行病学[J].中华肿瘤防治杂志,2006,13(18). 被引量:63
  • 3Hockemeyer D, Sfeir A J, Shay J W, et al. POT1 protects telorneres from a transient DNA danzage response and determines how human chromosomes end[J]. EMBO J, 2005,24(14) :2667-2678.
  • 4Wang F, Podell E R, Zaug A J, et al. The POT1 TPP1 telomere complex is a telomerase processivity factor[J]. Nature, 2007,445(7127):506-510.
  • 5Pool J C,Amdrews L G,Tollefsbol T O.Activity,function,and gene regulation of the catalgtic subunit of telomerase (chTERT)[J].Gene,2001,269:1-12
  • 6Moon I K,Jarstfer M B.The human telomere and its relationship to human disease,therapy,and tissue engineering[J].Front Biosci,2007,12(1):4595-4620.
  • 7Hornsby P J.Telomerase and the aging process[J].Exp Gerontol,2007,42(7):575-581.
  • 8Fakhoury J,Nimmo G A,Autexier C.Harnessing telomerase in cancer therapeutics[J].Anticancer Agents Med Chem,2007,7(4):475-483.
  • 9Koga S,Hirohata S,Kondo Y,et al.A novel telomerase-specific gene therapy:gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter[J].Hum Gene Ther,2000,11(10):1397-1406.
  • 10Gu J,Kagawa S,Takakura M,et al.Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers[J].Cancer Res,2000,60(19):5359-5364.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部